M
Michel Bouvier
Researcher at Université de Montréal
Publications - 412
Citations - 33931
Michel Bouvier is an academic researcher from Université de Montréal. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 97, co-authored 396 publications receiving 31267 citations. Previous affiliations of Michel Bouvier include École Polytechnique de Montréal & University of Catania.
Papers
More filters
Posted ContentDOI
Vasopressin V2 is a promiscuous G protein-coupled receptor that is biased by its peptide ligands
Franziska M. Heydenreich,Bianca Plouffe,Aurélien Rizk,Dalibor Milić,Joris Zhou,Billy Breton,Christian Le Gouill,Asuka Inoue,Michel Bouvier,Dmitry B. Veprintsev +9 more
TL;DR: The results showed that V2 receptor is not only promiscuous in its ability to engage several G proteins, but also that its signalling profile could be easily biased by small structural changes in the ligand.
Journal ArticleDOI
Métaphores, nomenclature et nouveaux paradigmes de signalisation par les récepteurs couplés aux protéines G
TL;DR: The RCPG as discussed by the authors is a family of recepteurs interagissant avec des proteines liant les nucleotides guanyles (proteines G).
Journal Article
Inverse agonists and g-protein-coupled receptors
Richard A. Bond,Michel Bouvier +1 more
Book ChapterDOI
Bioluminescence Resonance Energy Transfer (BRET) Imaging in Living Cells: Image Acquisition and Quantification.
TL;DR: In this paper, a method for high-resolution BRET imaging by combining bright-light output luciferases, such as NanoLuc, photon-counting EM-CCD, and unique algorithms for image correction and denoising is described.
Journal ArticleDOI
Transcriptome Analysis Reveals That G Protein-Coupled Receptors Are Potential Diagnostic Markers or Therapeutic Targets in Acute Myeloid Leukemia
Arhamatoulaye Maiga,Sébastien Lemieux,Caroline Pabst,Vincent-Philippe Lavallée,Michel Bouvier,Guy Sauvageau,Josée Hébert +6 more
TL;DR: expression of GPCRs in a large cohort of AML samples, as well as in normal blood cells, bone marrow cell populations, and cord blood-derived CD34+ cells as controls, demonstrated that several GPCR members are deregulated, thereby representing promising therapeutic targets or diagnostic markers.